trial

Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy

NCTId NCT03652974
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 145 (actual)
Sponsored by Shanghai Mental Health Center
Primary completion 2021-08-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
145 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2018-09-06
Primary completion
2021-08-30
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Clozapine

Sponsors

Shanghai Mental Health CenterLead Sponsor
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji UniversityCollaborator
The Affiliated Brain Hospital of Guangzhou Medical UniversityCollaborator

Investigators

1
Zezhi Li, M.D.Principal Investigator

Sites

1 total
Shanghai, China

Facts & assertions

4 sourced
Enrollment
145
Phase
PHASE4
Primary Completion Date
2021-08-30
Status
COMPLETED
relationships
The graph out of here
drug
Clozapine
drug
lead_sponsor
Shanghai Mental Health Center
company
collaborator
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
company
The Affiliated Brain Hospital of Guangzhou Medical University
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Zezhi Li, M.D.
person